Garcia Santa Cruz, Beatriz
Slter, Jan
Gomez-Giro, Gemma
Saraiva, Claudia
Sabate-Soler, Sonia
Modamio, Jennifer
Barmpa, Kyriaki
Schwamborn, Jens Christian
Hertel, Frank
Jarazo, Javier
Husch, Andreas
Funding for this research was provided by:
Fonds National de la Recherche Luxembourg (PRIDE17/12244779/PARK-QC)
Article History
Received: 18 October 2021
Accepted: 27 June 2022
First Online: 6 July 2022
Competing interests
: Javier Jarazo and Jens Christian Schwamborn are co-founders and shareholders of OrganoTherapeutics SARL. The rest of the authors declare no competing interests.